샘플 요청 목록

 카트 문의
시장보고서
상품코드
1760847

세계의 뇌종양 진단 및 치료 시장

Brain Tumor Diagnosis and Treatment
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 173 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

뇌종양 진단 및 치료 세계 시장은 2030년까지 20억 달러에 도달

2024년에 16억 달러로 추정되는 뇌종양 진단 및 치료 세계 시장은 2024-2030년간 CAGR 4.4%로 성장하여 2030년에는 20억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 원발성 뇌종양은 CAGR 4.1%를 나타내고, 분석 기간 종료까지 13억 달러에 이를 것으로 예측됩니다. 2차성 뇌종양 부문의 성장률은 분석 기간중 CAGR 4.8%로 추정됩니다.

미국 시장은 4억 1,050만 달러로 추정, 중국은 CAGR 7.7%를 보일 것으로 예측

미국의 뇌종양 진단 및 치료 시장은 2024년에는 4억 1,050만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 분석 기간인 2024-2030년간 CAGR 7.7%로 2030년까지 4억 5,510만 달러 규모에 이를 것으로 예측됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 1.7%와 4.6%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.7%를 보일 전망입니다.

세계의 뇌종양 진단 및 치료 시장 - 주요 동향과 촉진요인 정리

뇌종양 진단 및 치료 시장은 어떻게 진화하고 있는가?

뇌종양 진단 및 치료 시장은 영상기술의 발전과 표적치료제의 개발로 빠르게 진화하고 있습니다. 효과적인 치료를 위해서는 조기 진단이 필수적이며, MRI, CT 스캔, PET 스캔 등의 기술 혁신으로 검출 정확도가 향상되고 진단 시간이 단축되고 있습니다. 치료는 수술이나 방사선과 같은 전통적인 방법에서 표적 약물 치료나 면역치료와 같이 주변 건강한 조직의 손상을 최소화하면서 종양 세포를 보다 정확하게 공격하는 보다 진보된 치료법으로 전환되고 있습니다.

뇌종양 치료의 발전에서 기술은 어떤 역할을 하고 있는가?

AI 기반 진단 도구, 정위적 방사선 수술, 개인 맞춤형 의료 등의 혁신을 통해 뇌종양 치료의 발전에 혁신적 역할을 하고 있으며, AI 알고리즘은 기존 방법보다 더 높은 정확도로 의료 영상을 분석하여 종양의 검출 및 특성화 정확도를 향상시키고 있습니다. 향상시키고 있습니다. 감마나이프나 사이버나이프와 같은 정위적 방사선 수술은 건강한 조직에 미치는 영향을 최소화하면서 종양을 목표로 하는 비침습적이고 정밀한 방사선 치료를 가능하게 합니다. 유전자 프로파일링을 포함한 개인 맞춤형 치료 접근법은 환자 개개인프로파일에 맞는 표적 치료법을 개발할 수 있게 해줍니다.

시장 역학 및 환자층은 뇌종양 치료를 어떻게 형성하고 있는가?

시장 역학 및 환자층은 뇌종양 치료를 크게 좌우하고 있으며, 환자 중심의 맞춤 치료 접근법에 점점 더 중점을 두고 있습니다. 뇌종양 발병률 증가, 특히 고령화로 인해 보다 효과적이고 덜 침습적인 진단 및 치료 옵션에 대한 수요가 증가하고 있습니다. 또한, 뇌 건강에 대한 인식이 높아지고 신경종양학이 발전함에 따라 조기 진단과 다학제적 치료 계획이 장려되고 있습니다. 고급 의료에 대한 접근성의 지역적 격차도 시장 성장에 영향을 미치고 있지만, 북미와 유럽은 의료 인프라와 연구시설이 잘 갖추어져 있어 시장을 주도하고 있습니다.

뇌종양 진단 및 치료 시장의 성장을 가속하는 요인은 무엇인가?

뇌종양 진단 및 치료 시장의 성장은 영상 기술의 발전, 표적 치료 및 면역 요법의 개발, 전 세계 뇌종양 발생률 증가 등 여러 요인에 의해 주도되고 있습니다. 진단에 AI와 머신러닝의 통합은 감지율과 정확도를 향상시키고 있습니다. 비침습적 치료 옵션과 개인 맞춤형 의료에 대한 수요 증가는 시장을 혁신적인 접근 방식으로 이끌고 있습니다. 또한, 의료비 지출 증가, 인식 개선, 암 연구에 대한 정부 재정 지원도 시장 확대에 기여하고 있습니다.

부문

종양 유형(원발성 뇌종양, 연발성 뇌종양), 진단 유형(CT 스캔, MRI, PET-CT 스캔, 요추 천자, 뇌파, 조직 샘플링, 기타 진단 유형), 치료 유형(수술, 방사선 요법, 표적치료, 화학요법, 면역치료, 기타 치료 유형)

조사 대상 기업 예(총 42개사)

  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴로 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.07.08

Global Brain Tumor Diagnosis and Treatment Market to Reach US$2.0 Billion by 2030

The global market for Brain Tumor Diagnosis and Treatment estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.0 Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Primary Brain Tumor, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Secondary Brain Tumor segment is estimated at 4.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$410.5 Million While China is Forecast to Grow at 7.7% CAGR

The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$410.5 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$455.1 Million by the year 2030 trailing a CAGR of 7.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 4.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Brain Tumor Diagnosis and Treatment Market - Key Trends & Drivers Summarized

How Is the Brain Tumor Diagnosis and Treatment Market Evolving?

The brain tumor diagnosis and treatment market is evolving rapidly due to advancements in imaging technologies and the development of targeted therapies. Early diagnosis is critical for effective treatment, and innovations such as MRI, CT scans, and PET scans are enhancing detection accuracy and reducing diagnostic times. In terms of treatment, there is a shift from traditional methods like surgery and radiation to more advanced options such as targeted drug therapy and immunotherapy, which offer better precision in targeting tumor cells while minimizing damage to surrounding healthy tissues.

What Role Does Technology Play in Advancing Brain Tumor Treatment?

Technology is playing a transformative role in advancing brain tumor treatment through innovations like AI-powered diagnostic tools, stereotactic radiosurgery, and personalized medicine. AI algorithms are improving the accuracy of tumor detection and characterization by analyzing medical imaging with greater precision than conventional methods. Stereotactic radiosurgery, such as Gamma Knife and CyberKnife, allows for non-invasive, high-precision radiation treatment that targets tumors with minimal impact on healthy tissues. Personalized treatment approaches, including genetic profiling, are enabling the development of targeted therapies tailored to individual patient profiles.

How Are Market Dynamics and Patient Demographics Shaping Brain Tumor Care?

Market dynamics and patient demographics are significantly shaping brain tumor care, with an increasing emphasis on patient-centered and personalized treatment approaches. The rising incidence of brain tumors, particularly among aging populations, is driving demand for more effective and less invasive diagnostic and therapeutic options. Additionally, the growing awareness of brain health and advancements in neuro-oncology are encouraging early diagnosis and multidisciplinary treatment plans. Regional disparities in access to advanced care are also influencing market growth, with North America and Europe leading due to well-established healthcare infrastructure and research facilities.

What Factors Are Driving the Growth in the Brain Tumor Diagnosis and Treatment Market?

The growth in the brain tumor diagnosis and treatment market is driven by several factors, including advancements in imaging technologies, the development of targeted and immunotherapies, and the increasing incidence of brain tumors globally. The integration of AI and machine learning in diagnostics is improving detection rates and accuracy. The rising demand for non-invasive treatment options and personalized medicine is pushing the market towards innovative approaches. Furthermore, increasing healthcare expenditure, awareness, and government funding for cancer research are also contributing to the market's expansion.

SCOPE OF STUDY:

The report analyzes the Brain Tumor Diagnosis and Treatment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Tumor Type (Primary Brain Tumor, Secondary Brain Tumor); Diagnosis Type (CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling, Other Diagnosis Types); Treatment Type (Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy, Other Treatment Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • AstraZeneca PLC
  • Carestream Health, Inc.
  • GE Healthcare
  • Hitachi Medical Corporation
  • Merck & Co., Inc.
  • Pfizer, Inc.
  • Philips Healthcare
  • Shimadzu Corporation
  • Siemens Healthineers
  • Toshiba Medical Systems Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Tariff Impact on Global Supply Chain Patterns
    • Brain Tumor Diagnosis and Treatment - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Brain Tumors Driving Demand for Diagnostic and Treatment Solutions
    • Technological Advancements in MRI and CT Imaging for Early Tumor Detection
    • Growth in Targeted Therapy and Immunotherapy Applications for Brain Tumor Treatment
    • Increasing Adoption of AI and Machine Learning for Accurate Tumor Diagnosis
    • Expansion of Minimally Invasive Surgical Techniques in Brain Tumor Removal
    • Impact of Personalized Medicine and Genomic Studies on Treatment Strategies
    • Rising Investments in Research for Developing Advanced Diagnostic Tools
    • Growing Use of Radiotherapy and Radiosurgery in Brain Tumor Management
    • Development of Innovative Drug Delivery Systems for Brain Tumor Treatment
    • Emergence of Liquid Biopsy Techniques for Non-Invasive Diagnosis
    • Increasing Focus on Clinical Trials and Approvals for Novel Therapeutics
    • Impact of Healthcare Infrastructure Development in Emerging Markets on Accessibility
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Brain Tumor Diagnosis and Treatment Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Primary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Primary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Secondary Brain Tumor by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Secondary Brain Tumor by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for PET-CT Scan by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for PET-CT Scan by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lumbar Puncture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Lumbar Puncture by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Lumbar Puncture by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for EEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for EEG by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for EEG by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Tissue Sampling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Tissue Sampling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Tissue Sampling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Other Diagnosis Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Other Diagnosis Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Surgery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Surgery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Targeted Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Targeted Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Chemotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Chemotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Immunotherapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Immunotherapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Other Treatment Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Other Treatment Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 50: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: USA Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 53: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: USA Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 56: USA Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 59: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 62: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 65: Canada Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Canada Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Canada 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 68: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 71: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 74: Japan Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Japan Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Japan 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • CHINA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 77: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: China Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 80: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: China Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 83: China Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: China Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: China 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 86: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 87: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 89: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 92: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 95: Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 98: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: France Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 101: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: France Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 104: France Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: France Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: France 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 107: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 110: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 113: Germany Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Germany Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Germany 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 116: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 119: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 122: Italy Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Italy Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Italy 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 125: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: UK Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 128: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: UK Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 131: UK Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: UK Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: UK 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 134: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 137: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 140: Spain Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Spain Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Spain 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 143: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Russia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 146: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Russia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 149: Russia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Russia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Russia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Europe Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Europe Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Europe 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 162: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 170: Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 173: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Australia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 176: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Australia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 179: Australia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Australia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Australia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • INDIA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 182: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: India Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: India 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 185: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: India Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: India 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 188: India Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: India Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: India 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 191: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: South Korea 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 194: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: South Korea 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 197: South Korea Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: South Korea Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: South Korea 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Asia-Pacific Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Asia-Pacific 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 209: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 210: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 212: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 215: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 218: Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 221: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Argentina 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 224: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Argentina 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 227: Argentina Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Argentina Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Argentina 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 230: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Brazil 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 233: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Brazil 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 236: Brazil Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Brazil Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Brazil 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 239: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Mexico 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 242: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Mexico 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 245: Mexico Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 246: Mexico Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Mexico 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Rest of Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Rest of Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 254: Rest of Latin America Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Latin America Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Latin America 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 257: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 258: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 260: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 263: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 266: Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 269: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Iran 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 272: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Iran 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 275: Iran Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Iran Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Iran 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 278: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Israel 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 281: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Israel 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 284: Israel Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Israel Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: Israel 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: Saudi Arabia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: Saudi Arabia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 293: Saudi Arabia Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Saudi Arabia Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Saudi Arabia 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 296: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: UAE 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 299: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: UAE 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 302: UAE Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: UAE Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: UAE 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Rest of Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Rest of Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 311: Rest of Middle East Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Rest of Middle East Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 313: Rest of Middle East 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Brain Tumor Diagnosis and Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 314: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Tumor Type - Primary Brain Tumor and Secondary Brain Tumor Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 316: Africa 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Tumor Type - Percentage Breakdown of Value Sales for Primary Brain Tumor and Secondary Brain Tumor for the Years 2015, 2025 & 2030
    • TABLE 317: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 319: Africa 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Diagnosis Type - Percentage Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan, Lumbar Puncture, EEG, Tissue Sampling and Other Diagnosis Types for the Years 2015, 2025 & 2030
    • TABLE 320: Africa Recent Past, Current & Future Analysis for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Africa Historic Review for Brain Tumor Diagnosis and Treatment by Treatment Type - Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 322: Africa 15-Year Perspective for Brain Tumor Diagnosis and Treatment by Treatment Type - Percentage Breakdown of Value Sales for Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy, Immunotherapy and Other Treatment Types for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제